➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Express Scripts
Harvard Business School
Merck
Medtronic

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

MOMETASONE FUROATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for mometasone furoate and what is the scope of patent protection?

Mometasone furoate is the generic ingredient in six branded drugs marketed by Merck Sharp Dohme, Anda Repository, Cosette, Fougera Pharms, Glenmark Generics, Taro, Intersect Ent Inc, Perrigo Israel, Perrigo New York, Torrent, Amneal Pharms, and Apotex Inc, and is included in twenty-seven NDAs. There are thirteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Mometasone furoate has forty-five patent family members in twelve countries.

There are thirty drug master file entries for mometasone furoate. Seventeen suppliers are listed for this compound.

Drug Prices for MOMETASONE FUROATE

See drug prices for MOMETASONE FUROATE

Drug Sales Revenue Trends for MOMETASONE FUROATE

See drug sales revenues for MOMETASONE FUROATE

Recent Clinical Trials for MOMETASONE FUROATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Libbs Farmacêutica LTDAPhase 4
Lyra TherapeuticsPhase 2
Jeffrey GlassbergPhase 2

See all MOMETASONE FUROATE clinical trials

Pharmacology for MOMETASONE FUROATE
Medical Subject Heading (MeSH) Categories for MOMETASONE FUROATE
Paragraph IV (Patent) Challenges for MOMETASONE FUROATE
Tradename Dosage Ingredient NDA Submissiondate
NASONEX SPRAY, METERED;NASAL mometasone furoate 020762 2009-08-07
ELOCON LOTION;TOPICAL mometasone furoate 019796 2004-06-10
ELOCON CREAM;TOPICAL mometasone furoate 019625

US Patents and Regulatory Information for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms MOMETASONE FUROATE mometasone furoate SPRAY, METERED;NASAL 207989-001 Apr 3, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Cosette MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 077678-001 Nov 21, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Generics MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 090506-001 Aug 9, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MOMETASONE FUROATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-002 Feb 1, 2008   Start Trial   Start Trial
Merck Sharp Dohme ELOCON mometasone furoate LOTION;TOPICAL 019796-001 Mar 30, 1989   Start Trial   Start Trial
Merck Sharp Dohme ASMANEX TWISTHALER mometasone furoate POWDER;INHALATION 021067-001 Mar 30, 2005   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for MOMETASONE FUROATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0112669 96C0002 Belgium   Start Trial PRODUCT NAME: MOMETASONE FUROATE; NAT. REGISTRATION NO/DATE: NL 19601 19950919; FIRST REGISTRATION: GR - 10681/89 19900622
0548114 SPC/GB97/064 United Kingdom   Start Trial PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Mallinckrodt
Baxter
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.